ArticleCancer immunology, immunotherapy : CII2007

Intratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T cell avidity and anti-tumor activity.

Chie Kudo-Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.